Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Renale osteodystrophie.

Cejka D.

Wien Med Wochenschr. 2013 Sep;163(17-18):403-8. doi: 10.1007/s10354-013-0195-3. Epub 2013 May 9. Review.

PMID:
23657637
[PubMed - indexed for MEDLINE]
2.

Renal osteodystrophy.

Haas M.

Wien Med Wochenschr. 2004;154(5-6):107-18. Review.

PMID:
15106893
[PubMed - indexed for MEDLINE]
3.

Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.

Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E, Daramola-Ogunwuyi O, Fehmi H, Bhat S, Osman-Malik Y.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1484-1493. doi: 10.2215/CJN.01770408.

PMID:
19713297
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.

Fehmi H, Osman Y, Bhat S, Nguyen K, Daramola O, Cantor T, Monier-Faugere MC, Yee J, Malluche HH.

Clin Nephrol. 2009 Mar;71(3):267-75.

PMID:
19281737
[PubMed - indexed for MEDLINE]
5.
6.

25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.

Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E.

Kidney Int. 2005 Oct;68(4):1840-8.

PMID:
16164662
[PubMed - indexed for MEDLINE]
7.

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients.

Haas M, Leko-Mohr Z, Roschger P, Kletzmayr J, Schwarz C, Domenig C, Zsontsich T, Klaushofer K, Delling G, Oberbauer R.

Am J Kidney Dis. 2002 Mar;39(3):580-6.

PMID:
11877577
[PubMed - indexed for MEDLINE]
8.

New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.

Gal-Moscovici A, Popovtzer MM.

Clin Nephrol. 2005 Apr;63(4):284-9.

PMID:
15847255
[PubMed - indexed for MEDLINE]
9.

Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.

Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F.

Nephrol Dial Transplant. 1998 Sep;13(9):2294-302.

PMID:
9761512
[PubMed - indexed for MEDLINE]
Free Article
10.

Value of the new bone classification system in pediatric renal osteodystrophy.

Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1860-6. doi: 10.2215/CJN.01330210. Epub 2010 Jul 15.

PMID:
20634327
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.

Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.

Kidney Int. 2000 Feb;57(2):423-36.

PMID:
10652019
[PubMed - indexed for MEDLINE]
Free Article
12.

[Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].

Goto S, Fukagawa M.

Clin Calcium. 2007 Dec;17(12):1830-4. Review. Japanese.

PMID:
18057657
[PubMed - indexed for MEDLINE]
13.

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L; Bone Turnover Work Group.

Am J Kidney Dis. 2004 Mar;43(3):558-65. Review. No abstract available.

PMID:
14981615
[PubMed - indexed for MEDLINE]
14.

[Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation].

Kusec V, Smalcelj R.

Acta Med Croatica. 2004;58(1):51-7. Review. Croatian.

PMID:
15125394
[PubMed - indexed for MEDLINE]
15.

Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.

Lehmann G, Ott U, Kaemmerer D, Schuetze J, Wolf G.

Clin Nephrol. 2008 Oct;70(4):296-305.

PMID:
18826854
[PubMed - indexed for MEDLINE]
16.

Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.

Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.

Kidney Int. 2005 Sep;68(3):1206-14.

PMID:
16105052
[PubMed - indexed for MEDLINE]
17.

Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.

Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F.

Nephron. 2002 May;91(1):103-11.

PMID:
12021526
[PubMed - indexed for MEDLINE]
18.

[Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].

Jarava C, Armas JR, Palma A.

Nefrologia. 2000 Jul-Aug;20(4):362-72. Spanish.

PMID:
11039262
[PubMed - indexed for MEDLINE]
19.

Influence of PTH assay methodology on differential diagnosis of renal bone disease.

Reichel H, Esser A, Roth HJ, Schmidt-Gayk H.

Nephrol Dial Transplant. 2003 Apr;18(4):759-68.

PMID:
12637646
[PubMed - indexed for MEDLINE]
Free Article
20.

Bone disease in renal failure. Clinical and histomorphometric studies.

Nilsson P.

Scand J Urol Nephrol Suppl. 1984;84:1-68.

PMID:
6393322
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk